What do doctors mean by gynecomastia?
Gynecomastia refers to the benign enlargement of male breast tissue, specifically involving glandular rather than fatty tissue. This is different from pseudogynecomastia, where chest fullness is due to adipose (fat) tissue alone. True gynecomastia can usually be felt as a firm, rubbery disc of tissue beneath the nipple–areolar complex. It may be symmetrical or affect one side more than the other, and sometimes feels tender.
The term itself often raises concern, but in clinical practice, it simply describes a common anatomical change. Because the word “breast” is associated with femininity, it can lead to misunderstanding or embarrassment. Medically, however, it refers to anatomy shared by both sexes.
Understanding the difference between fatty tissue and glandular proliferation helps distinguish a benign condition from a cosmetic concern. During a clinical breast examination, a consultant like Dr D B Ghosh will carefully assess the type of tissue involved to provide clarity and reassurance without minimising the concern.
Pro Tip: Many cases of gynecomastia improve without treatment, especially in teenagers and young adults.
How is it different from male breast cancer?
Male breast cancer is rare, but it is understandably a source of concern for many men noticing changes in their chest. Unlike gynecomastia, which is typically soft, symmetrical, and located directly behind the nipple, male breast cancer may present as a hard, irregular lump, sometimes with skin dimpling, nipple changes, or discharge. These features are assessed during a clinical examination and may prompt further investigation if present. Most cases of gynecomastia, however, are benign and follow predictable, non-threatening patterns.
Why does gynecomastia develop at different stages of life?
Gynecomastia is not caused by a single underlying issue. Instead, it reflects hormonal imbalance in men, including shifts in the oestrogen–testosterone ratio that can occur during different life stages. It is most common in newborns, adolescents, and older men.
During puberty, hormonal fluctuations can temporarily trigger breast tissue development. Known as pubertal gynecomastia, this often resolves without treatment. In older adults, the balance between oestrogen and testosterone may change. This can be due to declining testosterone or increased aromatisation, which is the conversion of testosterone into oestrogen within body fat.
Some medications—including those for prostate health, heart conditions, or mental health—can influence hormone levels. Conditions affecting the liver, kidneys, or thyroid may also play a role in some patients. In other cases, no identifiable cause is found, and the condition is termed idiopathic.
Recognising these patterns helps clinicians assess whether the change is part of a normal physiological process or warrants further review.
Book a Private Gynecomastia Assessment
How is gynecomastia assessed in clinical practice?
Assessment begins with a thorough medical history. A breast surgeon will ask when the changes were first noticed, whether any discomfort is present, and if the patient has taken medications, supplements, or recreational drugs. Symptoms related to hormone imbalance or general health may also be discussed.
The next step is a physical examination. The surgeon will gently assess the chest for firmness, glandular texture, symmetry, and differences between sides. Palpable glandular tissue often feels firm and rubbery beneath the nipple–areolar area.
The examination helps distinguish between true gynecomastia, pseudogynecomastia, and less common conditions. It is a discreet, structured process designed to offer reassurance while gathering clinical detail. In the hands of an experienced consultant such as Dr D B Ghosh, the focus is always on thoughtful, calm evaluation. This structured approach helps confirm a gynecomastia diagnosis through clinical examination and history, without rushing to further testing.
When are further tests helpful—and when are they not?
Many patients worry that they will need scans or blood tests, but most cases of gynecomastia do not require these. Where the clinical picture is clear—symmetrical, soft, recent onset, and without other symptoms—investigations are usually unnecessary.
Tests may be helpful in some situations. Blood work might be recommended if hormone imbalances or systemic conditions are suspected. Male breast imaging, such as ultrasound, may be advised when the breast tissue is firmer than expected, asymmetric, or if there are red flag features such as nipple discharge or skin dimpling. Biopsy is rare and only suggested when cancer cannot be confidently excluded.
This selective use of testing helps avoid unnecessary procedures. At the same time, it ensures that concerning features are not missed. Clinical judgement plays a vital role in knowing when to act and when to watch.
How are treatment decisions made?
Treatment is never automatic. It depends on several factors, including how long the gynecomastia has been present, how it affects the patient physically and emotionally, and whether it is progressing.
What factors influence the choice to treat?
Duration of symptoms: How long the tissue has been present or changing.
Physical discomfort: Tenderness, pain, or sensitivity.
Emotional and social impact: Effects on self-confidence, clothing choices, or daily comfort.
Effect on daily activities: Avoidance of exercise or exposure, disruption to normal life.
This is where shared decision-making is essential. Emotional impact, including changes in confidence or social comfort, is also a valid and often under-recognised reason for seeking help or exploring treatment.
Some patients are comfortable with watchful waiting, especially when the condition is recent or expected to resolve. Others may experience physical discomfort or self-consciousness that prompts discussion about treatment.
The consultant explores the pros and cons of each option with the patient, considering symptom burden, preferences, and realistic expectations—often answering the question: ‘Do I need treatment for gynecomastia?’ Sometimes the best plan is to monitor changes over time and review decisions as needed.
Pro Tip: Ask your doctor about any medications or supplements that could be affecting your hormones.
What are the main approaches to managing gynecomastia?
Management falls into four broad categories:
Observation and follow-up: This is often the first step, particularly when the condition is recent or mild. Regular reviews ensure any changes are noted.
Reversible contributors: If a medication, supplement, or systemic condition is thought to play a role, addressing this may lead to improvement.
Medical therapy: In specific cases—particularly where symptoms are new, tender, or hormonally driven—selective oestrogen receptor modulators such as tamoxifen, a hormone-blocking medication originally developed for breast cancer, may be considered. These decisions are made under consultant guidance and tailored to the specific context of each patient.
Surgical management: When the glandular tissue causes persistent distress or does not resolve, surgery may be discussed. This can involve removal of glandular tissue or contour correction through liposuction, depending on the tissue type.
There is no set pathway. Each option is considered carefully, taking into account the patient’s individual symptoms, concerns, and overall clinical presentation.
Get a Consultant Opinion on Male Breast Changes
What can patients reasonably expect over time?
For many, gynecomastia will settle with time. This is especially true in adolescents or in cases where a specific reversible factor is identified. Even if it does not resolve completely, the condition often becomes stable and does not continue to progress.
Follow-up appointments provide an opportunity to monitor the situation and adjust decisions if symptoms evolve. In younger patients, especially those with pubertal gynecomastia, noticeable improvement often occurs over six months to two years. For others, particularly if a contributing factor is addressed, stabilisation or gradual reduction may follow within a similar timeframe.
Regular follow-up provides continued reassurance by confirming that there are no new or concerning developments. The emphasis is on clarity and continuity.
Patients can expect their concerns to be heard, their condition taken seriously, and their care managed without judgement.
A considered perspective
Gynecomastia is a common presentation in breast clinics and is not a reflection of personal failure or cosmetic concern alone. It is a physiological response to hormonal signals, sometimes transient and sometimes persistent.
For men who are unsure about whether their symptoms warrant assessment, a consultant-led review can provide clarity. At Dr D B Ghosh’s clinic, the approach combines breast cancer awareness, benign breast conditions expertise, and cosmetic sensitivity without assumptions. This ensures each patient receives a calm, structured, and professional explanation of their condition and options.
In most cases, the reassurance comes not from being told what to do, but from understanding what is happening and why—and what the sensible options are moving forward.
